About
Science
Pipeline
Investors & Media
FAQs
Contact
Investors & Media
All
Articles
Press Releases
Publications & Presentations
All
Articles
Press Releases
Publications & Presentations
Press Releases
Immusoft Announces FDA Clearance of IND Application for ISP-001 for MPS I, the First Engineered B Cell Therapy to Enter into Clinical Trials
September 1, 2022
Immusoft
Articles
A new gene therapy based on antibody cells is about to be tested in humans
September 1, 2022
MIT Technology Review
Press Releases
Immusoft to Present at WORLDSymposium™ 2022 Conference
February 7, 2022
Immusoft
Press Releases
Immusoft Receives $4M in Funding from the California Institute for Regenerative Medicine (CIRM)
November 29, 2021
Immusoft
Articles
Takeda to Work With Immusoft in $900 Million Rare-Disease Deal
October 13, 2021
Bloomberg
Articles
Drawn to the idea of turning B cells into ‘protein factories,’ Takeda jumps into a milestone-heavy, $900M pact
October 13, 2021
Endpoints News
Press Releases
Immusoft and Takeda Collaborate to Discover and Develop Cell Therapies for Rare Neurometabolic Disorders
October 13, 2021
Immusoft
Press Releases
Immusoft Announces Formation of Scientific Advisory Board
June 23, 2021
Immusoft
Press Releases
Immusoft to Present at ASGCT 23rd Annual Meeting
May 12, 2020
Immusoft
Press Releases
Immusoft to Present at WORLDSymposium™ 2020
February 5, 2020
Immusoft
Previous Page
1
2
3
4
5
More News
